Domesco Medical Import - Export Joint-Stock Corporation (HOSE:DMC)
Vietnam
· Delayed Price · Currency is VND 62,000
0.00 (0.00%)
At close: Apr 23, 2025
HOSE:DMC Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 1,899,427 | 1,719,032 | 1,592,727 | 1,498,395 | 1,451,954 | Upgrade
|
| Revenue Growth (YoY) | 10.49% | 7.93% | 6.30% | 3.20% | -1.12% | Upgrade
|
| Cost of Revenue | 1,481,947 | 1,346,931 | 1,139,838 | 1,096,779 | 1,013,488 | Upgrade
|
| Gross Profit | 417,480 | 372,101 | 452,889 | 401,616 | 438,466 | Upgrade
|
| Selling, General & Admin | 191,452 | 188,657 | 218,405 | 215,211 | 235,290 | Upgrade
|
| Operating Expenses | 191,452 | 188,657 | 218,405 | 215,211 | 235,290 | Upgrade
|
| Operating Income | 226,028 | 183,443 | 234,484 | 186,405 | 203,176 | Upgrade
|
| Interest Expense | - | - | - | - | -374.53 | Upgrade
|
| Interest & Investment Income | 25,044 | 40,645 | 18,977 | 11,612 | 14,521 | Upgrade
|
| Currency Exchange Gain (Loss) | 827.64 | 1,884 | -428.74 | 2,529 | 1,466 | Upgrade
|
| Other Non Operating Income (Expenses) | 862.48 | 2,895 | -2,942 | -1,486 | 1,165 | Upgrade
|
| EBT Excluding Unusual Items | 252,762 | 228,868 | 250,090 | 199,060 | 219,953 | Upgrade
|
| Gain (Loss) on Sale of Investments | 446.84 | 306.77 | 108.04 | 144.34 | 4,613 | Upgrade
|
| Gain (Loss) on Sale of Assets | 240.35 | - | - | - | - | Upgrade
|
| Pretax Income | 253,450 | 229,175 | 250,198 | 199,204 | 224,566 | Upgrade
|
| Income Tax Expense | 50,743 | 45,842 | 50,123 | 39,922 | 45,031 | Upgrade
|
| Net Income | 202,707 | 183,333 | 200,076 | 159,282 | 179,535 | Upgrade
|
| Preferred Dividends & Other Adjustments | 30,406 | 18,333 | 30,011 | 15,928 | 17,954 | Upgrade
|
| Net Income to Common | 172,301 | 164,999 | 170,064 | 143,354 | 161,582 | Upgrade
|
| Net Income Growth | 10.57% | -8.37% | 25.61% | -11.28% | -22.82% | Upgrade
|
| Shares Outstanding (Basic) | 35 | 35 | 35 | 35 | 35 | Upgrade
|
| Shares Outstanding (Diluted) | 35 | 35 | 35 | 35 | 35 | Upgrade
|
| EPS (Basic) | 4961.51 | 4751.27 | 4897.12 | 4127.96 | 4652.85 | Upgrade
|
| EPS (Diluted) | 4961.51 | 4751.00 | 4897.00 | 4127.96 | 4652.85 | Upgrade
|
| EPS Growth | 4.43% | -2.98% | 18.63% | -11.28% | -22.82% | Upgrade
|
| Free Cash Flow | -25,925 | 141,611 | 263,124 | 156,331 | -59,078 | Upgrade
|
| Free Cash Flow Per Share | -746.53 | 4077.79 | 7576.83 | 4501.65 | -1701.18 | Upgrade
|
| Dividend Per Share | - | 2500.000 | 2500.000 | 2500.000 | 2500.000 | Upgrade
|
| Gross Margin | 21.98% | 21.65% | 28.43% | 26.80% | 30.20% | Upgrade
|
| Operating Margin | 11.90% | 10.67% | 14.72% | 12.44% | 13.99% | Upgrade
|
| Profit Margin | 9.07% | 9.60% | 10.68% | 9.57% | 11.13% | Upgrade
|
| Free Cash Flow Margin | -1.36% | 8.24% | 16.52% | 10.43% | -4.07% | Upgrade
|
| EBITDA | 242,857 | 202,431 | 254,184 | 210,551 | 229,021 | Upgrade
|
| EBITDA Margin | 12.79% | 11.78% | 15.96% | 14.05% | 15.77% | Upgrade
|
| D&A For EBITDA | 16,829 | 18,987 | 19,700 | 24,146 | 25,845 | Upgrade
|
| EBIT | 226,028 | 183,443 | 234,484 | 186,405 | 203,176 | Upgrade
|
| EBIT Margin | 11.90% | 10.67% | 14.72% | 12.44% | 13.99% | Upgrade
|
| Effective Tax Rate | 20.02% | 20.00% | 20.03% | 20.04% | 20.05% | Upgrade
|
| Revenue as Reported | 1,899,427 | 1,719,032 | 1,592,727 | 1,498,395 | 1,451,954 | Upgrade
|
| Advertising Expenses | - | - | 44,220 | 51,629 | 57,286 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.